Valuation Rani Therapeutics Holdings, Inc.
Stocks
RANI
US7530181004
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 0.5263 USD | +0.21% |
|
-3.75% | -61.01% |
Company Valuation: Rani Therapeutics Holdings, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 322.3 | 145.8 | 85.92 | 45.64 | 131.7 | 60.75 | - | - |
| Change | - | -54.75% | -41.09% | -46.89% | 188.57% | -53.87% | - | - |
| Enterprise Value (EV) | 322.3 | 77.02 | 37.38 | 45.64 | 131.7 | 60.75 | 60.75 | 60.75 |
| Change | - | -76.1% | -51.46% | 22.08% | 188.57% | -53.87% | 0% | 0% |
| P/E | -38x | -4.61x | -2.5x | -1.3x | -3x | -3.14x | -2.77x | -3.36x |
| PBR | - | 7.91x | - | - | - | - | - | - |
| PEG | - | -0x | -0.64x | 0.1x | 0.1x | 0.1x | -0.2x | 0.2x |
| Capitalization / Revenue | 119x | - | - | 44.4x | 80.6x | 9.52x | 10.8x | 4.37x |
| EV / Revenue | 0x | - | - | 0x | 0x | 9.52x | 10.8x | 4.37x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.66x | -1.41x | -1.41x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.43 | -1.28 | -1.33 | -1.05 | -0.45 | -0.1675 | -0.19 | -0.1567 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2.717 | - | - | 1.028 | 1.633 | 6.382 | 5.646 | 13.91 |
| EBITDA | -51.1 | -62.9 | -65.28 | -52.29 | - | - | - | - |
| EBIT 1 | -51.6 | -63.45 | -66.1 | -49.6 | -38.31 | -36.6 | -43.03 | -42.97 |
| Net income 1 | -8.331 | -30.59 | -33.97 | -30.02 | -29.67 | -30.68 | -37.07 | -34.81 |
| Net Debt | - | -68.83 | -48.54 | - | - | - | - | - |
| Reference price 2 | 16.3500 | 5.9000 | 3.3200 | 1.3700 | 1.3500 | 0.5263 | 0.5263 | 0.5263 |
| Nbr of stocks (in thousands) | 19,712 | 24,720 | 25,880 | 33,312 | 97,551 | 115,425 | - | - |
| Announcement Date | 3/31/22 | 3/22/23 | 3/20/24 | 3/31/25 | 3/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.14x | - | - | - | 60.75M | ||
| 17.35x | 6.64x | 12.72x | 1.72% | 66.33B | ||
| 32.78x | 8.77x | 28.98x | 0.07% | 60.62B | ||
| 38.6x | 6.87x | 20.53x | 0.84% | 55.5B | ||
| 44.7x | 6.25x | 29.77x | -.--% | 47.58B | ||
| 34.6x | 3.29x | 14.2x | -.--% | 43.69B | ||
| -20.57x | 54.42x | -22.49x | -.--% | 37.27B | ||
| 36.15x | 8.94x | 23.31x | 0.36% | 36.57B | ||
| 40.59x | 7.91x | 26.38x | -.--% | 32.22B | ||
| -73.93x | 14x | -75.29x | -.--% | 26.58B | ||
| Average | 14.71x | 13.01x | 6.46x | 0.33% | 41B | |
| Weighted average by Cap. | 21.69x | 11.75x | 11.42x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- RANI Stock
- Valuation Rani Therapeutics Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
















